An initial subdivision of patients with breast cancer can be done by immunohistochemical techniques separating those whose malignant cells express either estrogen (ER) or progesterone receptors (PgR) and those that do not, as the first two can be treated with endocrine therapy. The gene discussed is PGR; the disease is breast carcinoma.